Updated Review of Nuclear Molecular Imaging of Thyroid Cancers

被引：10

作者：

Fu, Hao ^{[1
,2
]}

Sa, Ri ^{[1
,3
]}

Cheng, Lin ^{[1
]}

Jin, Yuchen ^{[1
]}

Qiu, Xian ^{[1
]}

Liu, Min ^{[1
,4
]}

Chen, Libo ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Dept Nucl Med, Affiliated Peoples Hosp 6, Yishan Rd 600, Shanghai 200233, Peoples R China

[2] Fujian Med Univ, Dept Nucl Med, Teaching Hosp, Xiamen Univ,Affiliated Hosp 1,Xiamen Canc Hosp, Xiamen, Peoples R China

[3] First Hosp Jilin Univ, Dept Nucl Med, Changchun, Peoples R China

[4] Fudan Univ, Zhongshan Hosp, Dept Nucl Med, Shanghai, Peoples R China

来源：

ENDOCRINE PRACTICE | 2021年 / 27卷 / 05期

基金：

中国国家自然科学基金;

关键词：

nuclear molecular imaging; thyroid cancer; nuclear medicine; radiopharmaceuticals; POSITRON-EMISSION-TOMOGRAPHY; PREABLATION 131-I SCANS; WHOLE-BODY SCAN; I-124; PET/CT; F-18-FDG PET; FOLLOW-UP; ASSOCIATION GUIDELINES; INCREASED CALCITONIN; SERUM THYROGLOBULIN; COMPUTED-TOMOGRAPHY;

D O I：

10.1016/j.eprac.2020.10.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives: We initiate this comprehensive review to update the advances in this field by objectively elucidating the efficacies of promising radiopharmaceuticals. Methods: We performed a comprehensive PUBMED search using the combined terms of "thyroid cancer" and "radiopharmaceuticals" or "nuclear medicine", yielding 3273 and 11026 articles prior to December 31, 2020, respectively. Results: Based on the mechanism of molecular metabolism, the evaluation of differentiated thyroid cancer and dedifferentiated thyroid cancer is largely centered around radioiodine and fluorine 18 (F-18)-fludeoxyglucose, respectively. Further, F-18-L-dihydroxyphenylalanine and gallium 68 DOTATATE are the preferred tracers for medullary thyroid cancer. In dedifferentiated medullary thyroid cancer and anaplastic thyroid cancer, F-18-fludeoxyglucose is superior. Conclusions: The future lies in advances in molecular biology, novel radiopharmaceuticals and imaging devices, paving ways to the development of personalized medication for thyroid cancer patients. (C) 2020 AACE. Published by Elsevier Inc. All rights reserved.

引用

页码：494 / 502

页数：9

共 99 条

[1] Effect of thyroid-stimulating hormone in 68Ga-DOTATATE PET/CT of radioiodine-refractory thyroid carcinoma: a pilot study [J].

Almeida, Ludmila S. ;

Araujo, Maidane C. ;

Zantut-Wittmann, Denise E. ;

Assumpcao, Ligia V. ;

Souza, Thiago F. ;

Silva, Cleide M. ;

Argenton, Juliana L. ;

Santos, Allan O. ;

Mengatti, Jair ;

Ramos, Celso D. ;

Etchebehere, Elba C. .

NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (05) :441-450

[2] 123I isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer:: Comparison with post 131I therapy whole body scanning [J].

Alzahrani, AS ;

Bakheet, S ;

Al Mandil, M ;

Al-Hajjaj, A ;

Almahfouz, A ;

Al Haj, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) :5294-5300

[3] Dedifferentiated thyroid cancer: A therapeutic challenge [J].

Antonelli, Alessandro ;

Fallahi, Poupak ;

Ferrari, Silvia Martina ;

Carpi, Angelo ;

Berti, Piero ;

Materazzi, Gabriele ;

Minuto, Michele ;

Guastalli, Mario ;

Miccoli, Paolo .

BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (08) :559-563

[4] 18F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma [J].

Archier, Aurelien ;

Heimburger, Celine ;

Guerin, Carole ;

Morange, Isabelle ;

Palazzo, Fausto F. ;

Henry, Jean-Francois ;

Schneegans, Olivier ;

Mundler, Olivier ;

Abdullah, Ahmad Esmaeel ;

Sebag, Frederic ;

Imperiale, Alessio ;

Taieb, David .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (06) :1027-1033

[5] Somatostatin receptor expression in thyroid disease [J].

Atkinson, Helen ;

England, James A. ;

Rafferty, Amy ;

Jesudason, Vim ;

Bedford, Karen ;

Karsai, Laszlo ;

Atkin, Stephen L. .

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2013, 94 (03) :226-229

[6] Differentiated Thyroid Cancer Outcomes After Surgery and Activity-Adjusted 131I Theragnostics [J].

Avram, Anca M. ;

Rosculet, Natalja ;

Esfandiari, Nazanene H. ;

Gauger, Paul G. ;

Miller, Barbra S. ;

Cohen, Mark ;

Hughes, David T. .

CLINICAL NUCLEAR MEDICINE, 2019, 44 (01) :11-20

[7] Preablation 131-I Scans With SPECT/CT Contribute to Thyroid Cancer Risk Stratification and 131-I Therapy Planning [J].

Avram, Anca M. ;

Esfandiari, Nazanene H. ;

Wong, Ka Kit .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (05) :1895-1902

[8] Preablation 131-I Scans With SPECT/CT in Postoperative Thyroid Cancer Patients: What Is the Impact on Staging? [J].

Avram, Anca M. ;

Fig, Lorraine M. ;

Frey, Kirk A. ;

Gross, Milton D. ;

Wong, Ka Kit .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (03) :1163-1171

[9] Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT [J].

Barwick, Tara ;

Murray, Iain ;

Megadmi, Hakim ;

Drake, William M. ;

Plowman, P. Nick ;

Akker, Scott A. ;

Chew, Shern L. ;

Grossman, Ashley B. ;

Avril, Norbert .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 162 (06) :1131-1139

[10] Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity [J].

Biermann, Martin ;

Krakenes, Jostein ;

Brauckhoff, Katrin ;

Haugland, Hans Kristian ;

Heinecke, Achim ;

Akslen, Lars A. ;

Varhaug, Jan Erik ;

Brauckhoff, Michael .

ACTA RADIOLOGICA, 2015, 56 (11) :1350-1360

← 1 2 3 4 5 6 7 8 9 10 →